Structured products present a challenge for STP technology

The continued growth of the structured products market is presenting challenges for straight through processing (STP) technology within OTC derivatives processing according to some experts.

Whilst speaking at the Misys Banking Systems event 'Best practices for STP within OTC derivatives processing', earlier this month, John Collins, Citigroup's London-based vice president of OTC Services, said structured products and the growth of exotic investments presents present one of the greatest

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

Most read articles loading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here